Chiome Bioscience Inc. (4583.T)
JPY 129.0
(-1.53%)
JPY 129.0
(-1.53%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.2 Billion JPY | 4.25% |
| 2022 | -1.25 Billion JPY | 5.67% |
| 2021 | -1.33 Billion JPY | -3.95% |
| 2020 | -1.28 Billion JPY | 8.44% |
| 2019 | -1.4 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -258.98 Million JPY | 19.61% |
| 2024 Q1 | -322.15 Million JPY | -7.44% |
| 2023 Q3 | -246.06 Million JPY | 43.21% |
| 2023 Q2 | -433.25 Million JPY | -91.71% |
| 2023 Q1 | -225.99 Million JPY | -3.04% |
| 2023 FY | -1.2 Billion JPY | 4.25% |
| 2023 Q4 | -299.85 Million JPY | -21.86% |
| 2022 Q3 | -260.11 Million JPY | 0.0% |
| 2022 FY | -1.25 Billion JPY | 5.67% |
| 2022 Q4 | -219.32 Million JPY | 15.68% |
| 2021 FY | -1.33 Billion JPY | -3.95% |
| 2020 FY | -1.28 Billion JPY | 8.44% |
| 2019 FY | -1.4 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 301.931% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -142.553% |
| GNI Group Ltd. | 13.1 Billion JPY | 109.194% |
| Linical Co., Ltd. | 725.72 Million JPY | 266.064% |
| Trans Genic Inc. | 89.43 Million JPY | 1447.52% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 15.483% |
| Soiken Holdings Inc. | -610 Million JPY | -97.566% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -55.96% |
| AnGes, Inc. | -11.96 Billion JPY | 89.93% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -7.528% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 87.349% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1255.493% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -39.42% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -7.895% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 4.503% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -50.918% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -257.23% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 9.766% |
| PeptiDream Inc. | 6.77 Billion JPY | 117.794% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 37.556% |
| Ribomic Inc. | -1.11 Billion JPY | -7.971% |
| SanBio Company Limited | -4.53 Billion JPY | 73.449% |
| Healios K.K. | -3.37 Billion JPY | 64.334% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -4.336% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 13.516% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 14.101% |
| StemRIM | -2.07 Billion JPY | 41.948% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 198.663% |
| FunPep Company Limited | -994 Million JPY | -21.244% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -35.601% |
| Stella Pharma Corporation | -760.3 Million JPY | -58.512% |
| TMS Co., Ltd. | -943.25 Million JPY | -27.767% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -55.427% |
| Cuorips Inc. | -588.48 Million JPY | -104.791% |
| K Pharma,Inc. | 366.05 Million JPY | 429.23% |
| Takara Bio Inc. | 3 Billion JPY | 140.132% |
| ReproCELL Incorporated | -409.29 Million JPY | -194.451% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 10993.682% |
| StemCell Institute Inc. | 413.75 Million JPY | 391.273% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 933.986% |
| CellSeed Inc. | -697.77 Million JPY | -72.716% |